The expression of paxillin has also been observed as closely associated with the prognosis and the lymph node metastasis of NSCLC patients (Salgia et al., 1999; Zuo and Li, 2003; Wu et al., 2010). This evidence concerns the gene PXN and metastatic malignant neoplasm in the lymph nodes.